StemCells Garners A Second $20M Grant From CIRM
This article was originally published in The Pink Sheet Daily
Executive Summary
StemCells gains $40 million in funding to move its stem cell treatment forward in two indications – Alzheimer’s disease and cervical spinal cord injury. The funding comes from the California Institute of Regenerative Medicine.